Report post
Jim Cramer discusses cannabis stock declines, emphasizing regulatory uncertainties in the US market. Curaleaf's executive chairman offers insights into the industry's 2024 outlook. Investors seek clarity on the sector's regulatory landscape, and CNBC shares Cramer's favorite marijuana stock, highlighting the complexities and potential of the cannabis market.

The World's Leading Crypto Trading Platform

Get my welcome gifts